Investing
AstraZeneca shares fall 3.6% to 7-1/2 week low
© Reuters. FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange, U.S., April 8, 2019. REUTERS/Brendan McDermid/File Photo
LONDON (Reuters) – Shares in London-listed drugmaker AstraZeneca (NASDAQ:) declined as much as 3.6% on Monday, falling to their lowest since July 19.
Traders attributed the move to a report in the Mail on Sunday newspaper saying the drugmaker’sChief Executive Pascal Soriot had said privately to friends and advisers that he may leave the company as soon as next year.
Reuters could not independently verify the information.
AstraZeneca declined to comment on the report.
Read the full article here
-
Side Hustles7 days ago
Mark Zuckerberg Is Now Second Richest Person in the World
-
Investing7 days ago
Nvidia CEO Jensen Huang: Demand For Blackwell AI Is Insane
-
Side Hustles7 days ago
Meta Previews Movie Gen, AI Tools That Turn Dreams to Videos
-
Investing5 days ago
Hurricane Helene Hits Spruce Pine Mine, Quartz Used for Tech
-
Investing6 days ago
Israel stocks lower at close of trade; TA 35 down 0.23% By Investing.com
-
Side Hustles6 days ago
5 Key Strategies for a Seamless Cloud Migration
-
Passive Income6 days ago
Go Paperless with the PDF Reader Pro for $49.99
-
Investing7 days ago
BCA says investors should fade the real estate rally By Investing.com